Immunovia, Inc., USA

In 2017, Immunovia, Inc. was established in Marlborough, Massachusetts. The IMMray™ PanCan-d test, the first blood-based test dedicated to the early detection of pancreatic cancer, will be offered as laboratory developed test (LDT) exclusively through Immunovia, Inc during Q3 2021.